Search this website. You can use fund codes to locate specific funds

Climate change and infectious diseases

As we manage our way through the coronavirus pandemic, we must not lose sight of the systemic risk posed by the climate crisis. In the second of our series, Nick Spooner explores how climate breakdown will exacerbate infectious diseases, and the steps that companies, investors and governments need to take to mitigate the impacts of the climate crisis and future pandemics.

Fast reading

  • Rising temperatures will expand the range over which mosquitoes can survive
  • Droughts and floods will increase in severity and frequency, impacting disease patterns
  • Post-pandemic economic stimulus should have climate change mitigation at its heart

Rising temperatures and subsequent changes to the climate will have a wide range of negative human health impacts, including the spread of infectious diseases. In part one of this series, we looked at how the unsustainable dynamic between humans and nature is increasing the probability of diseases emerging. Here we will assess how changing climatic conditions will exacerbate this phenomenon, as well as how environmental conditions will become increasingly favourable for infectious diseases to spread.

As with other physical climate risks, chronic or acute changes in the climate can act as a threat multiplier for infectious diseases. This gives cause for concern, with the total number of people exposed to infectious diseases projected to increase by 453-900 million by 2080, more than half of which will be accounted for by Europe. The chronic or long-term changes to the climate that are most relevant are changes in temperature, humidity and precipitation. Each of these has a positive, non-linear relationship with the spread of infectious diseases.

The Intergovernmental Panel on Climate Change (IPCC) projects that these changes will have an impact on the transmission intensity and seasonality of certain infectious diseases. However, it is difficult to draw simple causal relationships between these variables and the spread of disease. More research is required to better understand the complete set of dynamics. Furthermore, diseases may not spread in the same way due to the different vectors involved.

Vectors, particularly mosquitoes, are well adapted to warmer climates, and sensitive to small shifts in temperature. An increase in temperatures, therefore, will expand the range over which they can survive and transmit diseases such as malaria and dengue fever. According to The Lancet, a medical journal, nine of the 10 years that were most advantageous for the spread of dengue have occurred since 2000. Similarly, taking a baseline from 1950, the suitability for malaria has increased by 29.9%.

Droughts and floods, which are likely to increase in severity and frequency as the climate breaks down, will also impact disease patterns. The high levels of evaporation and demand for water during droughts increase the likelihood of the remaining water turning stagnant, forming ideal breeding grounds for mosquitoes and other vectors.

Conversely, studies in Panama have demonstrated how rat populations, another common disease vector, sharply increase following heavy rainfall and flooding. Also, there will be secondary impacts from these extreme weather events, such as changes in farmed land and increasing poverty, which will exacerbate societal vulnerabilities to infectious diseases. Shifting agricultural zones, following a decrease in productivity in many areas, will drive further interactions between humans and animals, as discussed in our previous article.

Economic stimulus

Uncertainty remains around when the coronavirus pandemic will begin to subside. When it does, it is critical that the inevitable economic stimulus has climate mitigation, adaptation and conservation at its heart. In this way, $26 trillion of economic benefits could be realised by 2030, while mitigating the impacts on health and society in the long term. Overdue infrastructure spending will certainly be a part of this, allowing for an acceleration in transitioning transport and energy systems.

However, it is important that governments reserve a portion of these stimulus packages for investing in research and development in the sectors that are more difficult to decarbonise. The Energy Transitions Commission, a think tank, has done an excellent job of drawing attention to the decarbonisation options for many of these ‘hard-to-abate’ sectors. The one sector that remains consistently overlooked is agriculture.

One option, as proposed by the Breakthrough Institute, is to increase the funding of research into alternative proteins. This would help to mitigate the impacts of the climate crisis, as the agricultural sector accounts for around 24% of global greenhouse gas emissions. At the same time, it would reduce the need to continue clearing virgin land for agriculture, which is a key driver of biodiversity loss and the emergence of infectious diseases. 

As we will explore in the next few articles in this series, an effective way to mitigate climate breakdown is to reduce our consumption of animal proteins, as the rearing of animals uses land inefficiently and produces a considerable amount of greenhouse gas emissions, whilst also increasing the risk of antimicrobial resistance.

Related Insights

Burberry case study
Burberry has reaffirmed its commitment to find alternatives to incinerating surplus stock in the midst of the coronavirus pandemic and set a science-based carbon reduction target.
The coronavirus and the race for a vaccine
With the coronavirus pandemic set to continue without an effective and widely-available vaccine, all eyes are on the pharmaceutical sector.
Mizuho Financial Group case study
Mizuho has made a commitment to ending financing of new coal-fired power plants and reducing exposure to coal-fired power plants to zero by 2050, the only Japanese bank to makes such a commitment.
A voting season like no other
With many companies opting for virtual shareholder meetings, how did investors ensure their concerns about climate change, diversity and human rights risks were addressed?
Antimicrobial resistance and the challenge for pharmaceutical companies
A lack of research and development into new antibiotic classes compounds the serious threat that antimicrobial resistance poses to public health.
Repsol case study
Repsol became the first oil and gas company to commit to a net-zero goal by 2050, supported by a decarbonisation pathway with interim targets, setting a higher benchmark for the industry. EOS has engaged with the company since 2013 on its climate action and targets.

EOS Client Service and Business Development

Amy D’Eugenio,
Head of Client Service and Business Development, EOS